115 related articles for article (PubMed ID: 8019891)
1. [Efficacy of immunotherapy with vaccination against hepatitis B virus on virus B multiplication].
Pol S; Driss F; Carnot F; Michel ML; Berthelot P; Brechot C
C R Acad Sci III; 1993 Jul; 316(7):688-91. PubMed ID: 8019891
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic vaccination in the immunotolerant phase of children with chronic hepatitis B infection.
Dikici B; Kalayci AG; Ozgenc F; Bosnak M; Davutoglu M; Ece A; Ozkan T; Ozeke T; Yagci RV; Haspolat K
Pediatr Infect Dis J; 2003 Apr; 22(4):345-9. PubMed ID: 12690275
[TBL] [Abstract][Full Text] [Related]
3. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection.
Ren F; Hino K; Yamaguchi Y; Funatsuki K; Hayashi A; Ishiko H; Furutani M; Yamasaki T; Korenaga K; Yamashita S; Konishi T; Okita K
J Med Virol; 2003 Nov; 71(3):376-84. PubMed ID: 12966542
[TBL] [Abstract][Full Text] [Related]
4. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus infection in allogeneic bone marrow transplantation.
Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of viral replication in children with chronic hepatitis B with and without interferon treatment.
Lazăr C; Grigorescu-Sido P; Manasia R; Mireştean S; Skorka C; Neculoiu D; Molnar G; Cocean S
Rom J Gastroenterol; 2005 Sep; 14(3):219-24. PubMed ID: 16200230
[TBL] [Abstract][Full Text] [Related]
7. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C.
Idilman R; De MN; Colantoni A; Nadir A; Van Thiel DH
Am J Gastroenterol; 2002 Feb; 97(2):435-9. PubMed ID: 11866284
[TBL] [Abstract][Full Text] [Related]
8. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
[TBL] [Abstract][Full Text] [Related]
9. Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection.
Marinos G; Naoumov NV; Williams R
Hepatology; 1996 Nov; 24(5):991-5. PubMed ID: 8903365
[TBL] [Abstract][Full Text] [Related]
10. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
[TBL] [Abstract][Full Text] [Related]
11. A multi-center open study to determine the effect of lamivudine on HBV DNA clearance and to assess the safety of the regimen in patients with chronic hepatitis B infection.
Mazur W; Król F; Cianciara J; Nazzal K; Gładysz A; Juszczyk J; Bolewska B; Adamek J; Czajka B; Swietek K; Kryczka W; Gonciarz Z
Med Sci Monit; 2002 Apr; 8(4):CR257-62. PubMed ID: 11951067
[TBL] [Abstract][Full Text] [Related]
12. Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.
Stephan C; Berger A; Carlebach A; Lutz T; Bickel M; Klauke S; Staszewski S; Stuermer M
J Antimicrob Chemother; 2005 Dec; 56(6):1087-93. PubMed ID: 16269552
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up.
Zavaglia C; Bottelli R; Bellati G; Asti L; Mondazzi L; Iamoni G; Zanetti A; Tanzi E; Fesce E; Gelosa F; Maggi G; Ideo G
Ital J Gastroenterol; 1996; 28(6):324-31. PubMed ID: 8891847
[TBL] [Abstract][Full Text] [Related]
14. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial.
Chung YH; Song BC; Lee GC; Shin JW; Ryu SH; Jung SA; Yoo K; Lee HC; Lee YS; Suh DJ
Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905
[TBL] [Abstract][Full Text] [Related]
15. Effects of indomethacin on viral replication markers in asymptomatic carriers of hepatitis B: a randomized, placebo-controlled trial.
Bahrami H; Daryani NE; Haghpanah B; Moayyeri A; Moghadam KF; Mirmomen S; Kamangar F
Am J Gastroenterol; 2005 Apr; 100(4):856-61. PubMed ID: 15784032
[TBL] [Abstract][Full Text] [Related]
16. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.
Lo CM; Liu CL; Chan SC; Lau GK; Fan ST
J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658
[TBL] [Abstract][Full Text] [Related]
17. An open-label study of lamivudine for chronic hepatitis B in six patients with chronic renal failure before and after kidney transplantation.
Ben-Ari Z; Broida E; Kittai Y; Chagnac A; Tur-Kaspa R
Am J Gastroenterol; 2000 Dec; 95(12):3579-83. PubMed ID: 11151895
[TBL] [Abstract][Full Text] [Related]
18. Occurrence and clinical outcome of lamivudine-resistant hepatitis B infection after liver transplantation.
Seehofer D; Rayes N; Steinmüller T; Müller AR; Settmacher U; Neuhaus R; Radke C; Berg T; Hopf U; Neuhaus P
Liver Transpl; 2001 Nov; 7(11):976-82. PubMed ID: 11699034
[TBL] [Abstract][Full Text] [Related]
19. [Follow-up of chronic hepatitis B carriers. Serological course and risk of reactivation].
Bujanda L; García Bengoechea M; Cilla G; Gil I; yArenas JI
Rev Esp Enferm Dig; 1996 May; 88(5):335-9. PubMed ID: 8764540
[TBL] [Abstract][Full Text] [Related]
20. [Natural history of hepatitis B virus infection in dialysis patients: prospective study by quantitative analysis of HBV viremia].
Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagliari B; Bisegna S; Tettamanzi F; Ponticelli C
G Ital Nefrol; 2002; 19(3):294-300. PubMed ID: 12195397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
